Sagimet Biosciences (SGMT) Change in Cash (2022 - 2024)

Sagimet Biosciences' Change in Cash history runs 3 years deep, the most recent figure standing at -$80.8 million for Q2 2024.

• In Q2 2024, Change in Cash fell 1409.85% year-over-year to -$80.8 million; the TTM figure through Jun 2024 stood at $4.3 million (down 97.48% YoY), while the FY2025 annual figure was $1.6 million, up 114.43% from the prior year.
• Change in Cash was -$80.8 million for Q2 2024 at Sagimet Biosciences, down from $101.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $156.2 million in Q4 2022 to a low of -$99.8 million in Q4 2023.
• Historically, Change in Cash has averaged $22.1 million across 3 years, with a median of $9.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Cash surged 3830.26% in 2023, then tumbled 1409.85% in 2024.
• A 3-year view of Change in Cash shows it stood at $156.2 million in 2022, then sank by 163.9% to -$99.8 million in 2023, then climbed by 19.03% to -$80.8 million in 2024.
• The last three Change in Cash figures came in at -$80.8 million (Q2 2024), $101.6 million (Q1 2024), and -$99.8 million (Q4 2023), per Business Quant data.